Toggle Dropdown
Announcements
Projects
Welcome guest
Log in
Loading
Loading...
https://www.cnbc.com/2023/11/30/biotech-stocks-jump-on-abbvie-deal-to-buy-cancer-drugmaker-immunogen.html
0
0
Biotech stocks jump on AbbVie deal to buy cancer drugmaker ImmunoGen for $10 billion - CNBC
+ 14 more
11/30/23 at 5:28pm
Organization
CNBC
Author
Annika Kim Constantino
Details
39 words
Summarize
Pharmaceuticals & Biotech
Business & Industrial
ADCs
AbbVie
ImmunoGen
CNBC
Shares of other biotech companies developing ADCs, which are among the hottest areas in the pharmaceutical industry, jumped on the news of the buyout.
Show more
Create an account
or
login
to join the discussion
Modal title
...
Profile
Loading profile
Loading...